Natural products and their structural derivatives have long played a crucial role in the discovery of new medical treatments and pharmacotherapies. However, certain natural compounds, such as toxins, are classified as hazardous substances that pose risk to human health. It is desirable to modulate the activity of toxins to minimize their harmful effects and unleash their potential as selective and bioavailable drugs. Yet, the functionalization of natural products remains a challenge due to their structural complexity. Here, we present two methods for late-stage C-H nitration and subsequent derivatization of the alkaloid steroidal neurotoxin veratridine, a sodium channel opener, by introducing an azobenzene photoswitch in its structure. The resulting compound, Azoveratridine, displays aqueous solubility, reversible photoisomerization, and light-dependent activity in neurons and myocardial slices.

Late-stage modification of the alkaloid toxin veratridine to photocontrol excitable tissues / L. Camerin, G. Maleeva, A. Ramírez-Abreu, V. Cilleros-Mañé, D. Miftari, M. Batlle, C. Matera, E. Guasch, P. Gorostiza. - In: BIOMÉDECINE & PHARMACOTHÉRAPIE. - ISSN 0753-3322. - 200:(2026 Jul), pp. 119546.1-119546.10. [10.1016/j.biopha.2026.119546]

Late-stage modification of the alkaloid toxin veratridine to photocontrol excitable tissues

C. Matera;
2026

Abstract

Natural products and their structural derivatives have long played a crucial role in the discovery of new medical treatments and pharmacotherapies. However, certain natural compounds, such as toxins, are classified as hazardous substances that pose risk to human health. It is desirable to modulate the activity of toxins to minimize their harmful effects and unleash their potential as selective and bioavailable drugs. Yet, the functionalization of natural products remains a challenge due to their structural complexity. Here, we present two methods for late-stage C-H nitration and subsequent derivatization of the alkaloid steroidal neurotoxin veratridine, a sodium channel opener, by introducing an azobenzene photoswitch in its structure. The resulting compound, Azoveratridine, displays aqueous solubility, reversible photoisomerization, and light-dependent activity in neurons and myocardial slices.
Agonist; Antihypertensive; Azobenzene; Cancer; Inactivation; Natural product; Neuromodulation; Opener; Optopharmacology; Photochromism; Photopharmacology; Photoswitch; Photoswitchable toxin; Steroid; VTD; Veratridine; Veratrum; Voltage-gated sodium channel (VGSC);
Settore CHEM-07/A - Chimica farmaceutica
Settore BIOS-11/A - Farmacologia
Settore CHEM-05/A - Chimica organica
   LUMINESCENT IMPLANTS AS PORTS FOR LIGHT-BASED THERAPIES
   PHOTOTHERAPORT
   European Commission
   Horizon Europe Framework Programme - HORIZON EIC Grants
   101130883

   Human Brain Project Specific Grant Agreement 3 (HBP SGA3)
   HBP SGA3
   EUROPEAN COMMISSION
   H2020
   945539

   DEEP BRAIN PHOTONIC TOOLS FOR CELL-TYPE SPECIFIC TARGETING OF NEURAL DISEASES
   DEEPER
   European Commission
   Horizon 2020 Framework Programme - Research and Innovation action
   101016787
lug-2026
25-mag-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0753332226005822-main.pdf

accesso aperto

Descrizione: main text
Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 3.21 MB
Formato Adobe PDF
3.21 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1250580
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact